Marella Thorell is Director of Vallon Pharmaceuticals, Inc.. Currently has a direct ownership of 9,506 shares of VLON, which is worth approximately $0. The most recent transaction as insider was on Dec 13, 2022, when has been sold 28,517 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 9.51K
0% 3M change
0% 12M change
Total Value Held $0

Marella Thorell Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 13 2022
SELL
Other acquisition or disposition
-
28,517 Reduced 75.0%
9,506 Common Stock
Jul 01 2022
BUY
Grant, award, or other acquisition
-
38,023 Added 50.0%
38,023 Common Stock

Also insider at

EPIX
ESSA Pharma Inc. Healthcare
CNTA
Centessa Pharmaceuticals plc Healthcare
MCRB
Seres Therapeutics, Inc. Healthcare
EVLO
Evelo Biosciences, Inc. Healthcare
SESN
Sesen Bio, Inc. Healthcare
MT

Marella Thorell

Director
Philadelphia, PA

Track Institutional and Insider Activities on VLON

Follow Vallon Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VLON shares.

Notify only if

Insider Trading

Get notified when an Vallon Pharmaceuticals, Inc. insider buys or sells VLON shares.

Notify only if

News

Receive news related to Vallon Pharmaceuticals, Inc.

Track Activities on VLON